J. Cornicelli

发表

Attenuation of collagen-induced arthritis by orally available imidazoline-based NF-κB inhibitors.

R. W. Henry, Theresa A Lansdell, J. Mccormick, 2012, Bioorganic & medicinal chemistry letters.

Reprint of BMCL_19101.

R. W. Henry, Theresa A Lansdell, J. Mccormick, 2012, Bioorganic & medicinal chemistry letters.

Macrophage-specific expression of class A scavenger receptors enhances granuloma formation in the absence of increased lipid deposition.

A. Daugherty, D. Rateri, J. Cornicelli, 2001, Journal of lipid research.

Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats

G. Oxenkrug, P. Summergrad, J. Cornicelli, 2016, Integrative molecular medicine.

Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy.

J. Pandit, C. Whitehead, Cindy Spessard, 2013, Bioorganic & medicinal chemistry letters.

Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.

A. Saltiel, J. Cornicelli, J. Davis, 1997, Metabolism: clinical and experimental.

Effect of cadmium ingestion on cadmium and zinc profile in male and female rat liver cytosol.

J. Boyle, J. Cornicelli, R. El-Gazzar, 1978, Biochemical pharmacology.

Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

A. Tall, C. Blum, R. Deckelbaum, 1982, The Journal of clinical investigation.

Mouse peritoneal macrophages contain abundant omega-6 lipoxygenase activity that is independent of interleukin-4.

A. Daugherty, B. Auerbach, S. Feinmark, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages.

A. Daugherty, D. Rateri, J. Cornicelli, 2000, Journal of lipid research.

A Rapid Screening Test to Determine the Antioxidant Potencies of Natural and Synthetic Antioxidants.

W. Pryor, B. Tait, D. Witiak, 1993 .

Inhibition of LDL Degradation in Cultured Human Fibroblasts Induced by Endothelial Cell‐Conditioned Medium

D. Goodman, J. Cornicelli, L. Witte, 1983, Arteriosclerosis.

A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid.

B. Auerbach, J. Cornicelli, J. Kiely, 1992, Analytical biochemistry.

Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells.

H. Kamitani, T. Eling, J. Cornicelli, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Human and monkey corneal endothelium expression of low-density lipoprotein receptors.

S. Elner, V. Elner, H. Davis, 1991, American journal of ophthalmology.

Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo.

A. Daugherty, M. Grusby, J. Cornicelli, 1998, Journal of immunology.

12/15-Lipoxygenase Expression In Vivo Fails to Diminish Macrophage Absence of T Lymphocyte-Derived Cytokines

A. Daugherty, M. Grusby, J. Cornicelli, 1998 .

Platelet-derived growth factor stimulates low density lipoprotein receptor activity in cultured human fibroblasts.

J. Cornicelli, L. Witte, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Effect of platelet-derived and endothelial cell-derived growth factors on the low density lipoprotein receptor pathway in cultured human fibroblasts.

R. Miller, D. Goodman, J. Cornicelli, 1982, The Journal of biological chemistry.

Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold technique.

I. Goldberg, D. Handley, J. Cornicelli, 1988, Biochimica et biophysica acta.

A VIRILIZING ADRENAL TUMOR WITH BORDERLINE ELEVATION OF URINARY 17‐KETOSTEROIDS AND HISTOCHEMICAL DEMONSTRATION OF A DEFICIENCY IN THE δ5/δ4‐ISOMERASE, 3β‐HYDROXYSTEROID DEHYDROGENASE ENZYMATIC SYSTEM

J. Cornicelli, R. M. Neto, J. Oliveira, 1979 .

A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants

W. Pryor, B. Tait, D. Witiak, 1993 .

N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.

B. Finzel, J. Brieland, S. Przybranowski, 2007, Bioorganic & Medicinal Chemistry Letters.

Cannabinoids Impair the Formation of Cholesteryl Ester in Cultured Human Cells

S. R. Gilman, J. Cornicelli, B. Kottke, 1981, Arteriosclerosis.

Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors.

Howard Miller, J. Pandit, C. Whitehead, 2013, Bioorganic & medicinal chemistry letters.

Alteration in Lipid Content of the Liver in the Rat After Partial Hepatectomy.∗

J. Cornicelli, A. Camargo, S. Cardoso, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism

B. Markham, C. Bisgaier, J. Cornicelli, 2018, Molecular and Cellular Biochemistry.

Is there a role for 15-lipoxygenase in atherogenesis?

S. Feinmark, J. Cornicelli, 1997, Biochemical pharmacology.

Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

L. Chan, C. Bisgaier, J. Cornicelli, 1995, The Journal of clinical investigation.

Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase.

I. Goldberg, J. Cornicelli, J. Paterniti, 1986, Biochimica et biophysica acta.

Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain

B. Markham, C. Bisgaier, J. Cornicelli, 2018, Front. Pharmacol..

15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease.

J. Cornicelli, B. K. Trivedi, 1999, Current pharmaceutical design.

Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.

R. Homan, A. Essenburg, J. Cornicelli, 1993, The Journal of pharmacology and experimental therapeutics.

A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit.

A. Daugherty, T. Bocan, J. Cornicelli, 1998, Atherosclerosis.

Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties

R. D. Dyer, B. Tait, A. Daugherty, 1997, British journal of pharmacology.

Transient overexpression of human 15-lipoxygenase in aortic endothelial cells enhances tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression.

J. Wölle, U. Saxena, J. Cornicelli, 1996, Biochemical and biophysical research communications.

Catechol based inhibitors of 15-lipoxygenase

B. Tait, R. Dyer, B. Roth, 1996 .

Scavenger receptors are present on rabbit aortic endothelial cells in vivo.

A. Daugherty, D. Rateri, J. Cornicelli, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Macrophage-specific expression of class A scavenger receptors in LDL receptor−/− mice decreases atherosclerosis and changes spleen morphology DOI 10.1194/jlr.M200116-JLR200

Alan Daugherty, Debra L Rateri, A. Daugherty, 2002, Journal of Lipid Research.

Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism

B. Markham, C. Bisgaier, J. Cornicelli, 2018, Molecular and Cellular Biochemistry.